Idexx Laboratories (IDXX) Net Margin (2009 - 2026)

Idexx Laboratories' Net Margin history runs 18 years deep, the most recent figure standing at 24.41% for Q1 2026.

• In Q1 2026, Net Margin rose 10.0% year-over-year to 24.41%; the TTM figure through Mar 2026 stood at 24.63% (up 187.0% YoY), while the FY2025 annual figure was 24.62%, up 184.0% from the prior year.
• Net Margin was 24.41% for Q1 2026 at Idexx Laboratories, up from 22.76% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 26.5% in Q2 2025 to a low of 15.34% in Q2 2022.
• Historically, Net Margin has averaged 22.77% across 5 years, with a median of 23.19% in 2022.
• The sharpest annual moves came in 2022 and 2023: Net Margin slumped 910 bps in 2022, then soared 843 bps in 2023.
• A 5-year view of Net Margin shows it stood at 20.78% in 2022, then grew by 4 bps to 21.58% in 2023, then advanced by 5 bps to 22.65% in 2024, then rose by 0 bps to 22.76% in 2025, then advanced by 7 bps to 24.41% in 2026.
• The last three Net Margin figures came in at 24.41% (Q1 2026), 22.76% (Q4 2025), and 24.85% (Q3 2025), per Business Quant data.